Criteria
National Institutes of Health consensus development statement [1]
Classical phenylketonuria (PKU): a disorder associated with high levels of blood phenylalanine (phe) (typically >1211 micromol/L [20 mg/dL]) and a complete absence or profound deficiency of phenylalanine hydroxylase (PAH) activity.[1]
Non-PKU hyper-phenylalaninaemia: a lower elevation of blood phe.
Exclusion of tetrahydrobiopterin (BH4) deficiency states is not specifically mentioned in definition but assumed.
European classification[2]
Classical PKU: complete or near-complete deficiency of hepatic PAH activity accompanied in the patient by a dietary phe tolerance of <250-350 mg/day.
Moderate PKU: characterised by a dietary phe tolerance of 350-400 mg/day.
Mild PKU: characterised by a dietary phe tolerance of 400-600 mg/day.
Mild hyper-phenylalaninaemia: a condition in which plasma phe levels are <605 micromol/L (10 mg/dL) on a normal diet.
Common practice in the US
Classical PKU: blood phe on unrestricted diet >1211 micromol/L (20 mg/dL).
Non-PKU hyper-phenylalaninaemia:
Mild-to-moderate or non-classical PKU: blood phe on unrestricted diet above the threshold for triggering intervention but <1211 micromol/L (20 mg/dL).
Benign hyper-phenylalaninaemia: blood phe on unrestricted diet above normal but below the threshold for triggering intervention (typically the threshold is 363 micromol/L [6 mg/dL]).
Patients who have hyper-phenylalaninaemia resulting from rare defects in tetrahydrobiopterin synthesis or recycling are excluded from this definition.
Use of this content is subject to our disclaimer